Background: The present study investigated the prevalence of depression in HIV-positive individuals and its association with adherence to highly active antiretroviral therapy (HAART).
Methods: HIV-positive (n = 80) and HIV-negative (n = 20) participants were assessed for depression and adherence via clinical interview and self-reporting.
Results: Fourteen percent of the HIV-seropositive group met the criteria for current mood disorder compared with 5% of controls.